Navigating the European medtech regulatory jungle? Good news—real progress is ahead.
In her latest column in Medtech Magazine, Anna-Karin Alm, Head of QARA at Aurevia, explores how the convergence of regulations, such as the MDR, IVDR and AI Act, are reshaping the path to market for medical devices.
While today’s regulatory landscape can feel overwhelming for innovators, AI-driven tools and regulatory sandboxes are emerging as game-changers, making compliance more accessible and innovation more achievable.
Read the full article at Medtech Magazine (in Swedish) to see what’s on the horizon for the future of medtech.